Araca Energy ASA:石油・ガス:M&Aディール及び事業提携情報

◆英語タイトル:Araca Energy ASA - Oil & Gas - Deals and Alliances Profile
◆商品コード:DATA904C6701
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Araca Energy ASA (Araca Energy), formerly Aladdin Oil & Gas Company ASA is an oil and gas company that explores, acquires, extracts, develops, and produces oil and gas assets in Russia and other countries. The company conducts its oil and gas exploration, production and operations through its subsidiary that has exploration and production licenses in the Timan-Pejora province in Northwest Russia. It owns and operates exploration and production licenses in the Komi Republic of the Russian Federation. Araca Energy’s West Ukhtinskoye license block is located between the Yarega heavy oil field (Lukoil) and Chibyu light oil field extracting and producing oils and gas assets. The company also owns and operates Izerbash and Sulak exploration blocks in the Caspian Sea, Dagestan. Araca Energy is headquartered in Oslo, Norway.

Araca Energy ASA – Oil & Gas – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Oil & Gas eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Araca Energy ASA, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Araca Energy ASA, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Araca Energy ASA, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Araca Energy ASA, Oil & Gas, Deals By Sector, 2012 to YTD 2018 8
Araca Energy ASA, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Araca Energy ASA, Oil & Gas, Deal Details 10
Acquisition 10
Araca Energy Acquires Geopromneft 10
Araca Energy To Acquire Petrarko In Reverse Takeover Transaction 11
Araca Energy Completes Acquisition Of 27.5% Stake In Timan Oil and Gas From Levant Energy For US$193.2 Million 12
Araca Energy ASA – Key Competitors 13
Araca Energy ASA – Key Employees 14
Araca Energy ASA – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Mar 27, 2018: Araca Energy: Finalisation Of Delayed Consolidated Financial Statements 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Araca Energy ASA, Oil & Gas, Key Facts 2
Araca Energy ASA, Oil & Gas, Deals Summary, 2012 to YTD 2018 2
Araca Energy ASA, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Araca Energy ASA, Oil & Gas Deals By Type, 2012 to YTD 2018 6
Araca Energy ASA, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Araca Energy ASA, Deals By Sector, 2012 to YTD 2018 8
Araca Energy ASA, Oil & Gas, Deals Summary, 2012 to YTD 2018 9
Araca Energy Acquires Geopromneft 10
Araca Energy To Acquire Petrarko In Reverse Takeover Transaction 11
Araca Energy Completes Acquisition Of 27.5% Stake In Timan Oil and Gas From Levant Energy For US$193.2 Million 12
Araca Energy ASA, Key Competitors 13
Araca Energy ASA, Key Employees 14
Araca Energy ASA, Subsidiaries 15

List of Figures
Araca Energy ASA, Oil & Gas, Deals by Type, 2012 to YTD 2018 2
Araca Energy ASA, Oil & Gas, Deals By Year, 2012 to YTD 2018 2
Araca Energy ASA, Oil & Gas, Deals By Region, 2012 to YTD 2018 2
Araca Energy ASA, Oil & Gas, Deals By Sector, 2012 to YTD 2018 2
Araca Energy ASA, Oil & Gas, Deals By Year, 2012 to YTD 2018 5
Araca Energy ASA, Oil & Gas, Deals by Type, 2012 to YTD 2018 6
Araca Energy ASA, Oil & Gas, Deals By Region, 2012 to YTD 2018 7
Araca Energy ASA, Oil & Gas, Deals by Sector, 2012 to YTD 2018 8

★海外企業調査レポート[Araca Energy ASA:石油・ガス:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Faron Pharmaceuticals Oy (FARN):医療機器:M&Aディール及び事業提携情報
    Summary Faron Pharmaceuticals Oy (Faron) is a clinical stage biopharmaceutical company that conducts clinical stage drug discovery and development. The company's pipeline products focus on cute organ traumas, vascular damage and cancer immunotherapy. It offers Traumakine, that helps to prevent vascu …
  • Genedata AG:医療機器:M&Aディール及び事業提携情報
    Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, …
  • Country Club Hospitality & Holidays Ltd.
    Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report Summary Country Club Hospitality & Holidays Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Urban Outfitters Inc:企業の戦略・SWOT・財務情報
    Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report Summary Urban Outfitters Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • CVRx Inc:医療機器:M&Aディール及び事業提携情報
    Summary CVRx Inc (CVRx) is a medical device company that develops and designs implantable device. The company provides barostim neo system, which is designed to trigger the body’s natural blood flow regulation system to treat high blood pressure and heart failure. Its products are used in the treatm …
  • Norsk Hydro ASA (NHY):電力:M&Aディール及び事業提携情報
    Summary Norsk Hydro ASA (Hydro) is a global supplier of aluminum and an electricity producer. Its operations span the value chain, from bauxite extraction to the production of rolled and extruded aluminum products and building systems. Its portfolio of products include bauxite, alumina, extrusion in …
  • Aradigm Corp (ARDM):医療機器:M&Aディール及び事業提携情報
    Summary Aradigm Corp (Aradigm) is a specialty pharmaceutical company that develops and commercializes inhalation drugs for the prevention and treatment of severe respiratory diseases. The company's product pipeline includes Pulmaquin (ARD-3150) and Lipoquin (ARD-3100) for the treatment of non-cystic …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • El Al Israel Airlines Ltd.:企業の戦略・SWOT・財務情報
    El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report Summary El Al Israel Airlines Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • IHI Corporation:企業のM&A・事業提携・投資動向
    IHI Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IHI Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Clean Harbors Inc (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors Inc (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Cincinnati Bell Inc (CBB):企業の財務・戦略的SWOT分析
    Cincinnati Bell Inc (CBB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Scilex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scilex Pharmaceuticals Inc (Scilex Pharma), a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch tec …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Oberoi Realty Limited:企業の戦略・SWOT・財務情報
    Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report Summary Oberoi Realty Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Celmatix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Celmatix Inc (Celmatix) is a medicine company that develops infertility treatment products. The company provides products such as Polaris, an analytics platform for optimizing a woman’s fertility; and Fertilome test is a next generation sequencing panel that reveals genetic factors significa …
  • Nuance Communications, Inc.:企業の戦略・SWOT・財務情報
    Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nuance Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • SalvaRx Group plc (SALV):企業の財務・戦略的SWOT分析
    Summary SalvaRx Group Plc (SalvaRx), formerly 3Legs Resources plc, is a drug development company that offers acquiring and operating drug development programmes in immuno-oncology. The company offers immune oncology. It invests in novel cancer immune-therapies. SalvaRx provides development of a pipe …
  • Endurance International Group Holdings, Inc.:企業のM&A・事業提携・投資動向
    Endurance International Group Holdings, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Endurance International Group Holdings, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • BELLUS Health Inc (BLU):製薬・医療:M&Aディール及び事業提携情報
    Summary BELLUS Health Inc (BELLUS Health) is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company’s pipeline products include BLU-5937 for chronic cough, Shigamab for STEC related hemolytic syndrome (sHUS); KIACTA for the treatment of a second ind …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆